This might help you. BOT may be under charging... Chat GPT says....Top 10 High-Cost Prescription Drugs Under $1,000/Month (Typically Covered by Insurance)
Medication Condition Treated Estimated Monthly Cost (USD) Insurance Coverage 1 Ozempic (semaglutide) Type 2 Diabetes ~$936 Often covered; copay cards may reduce cost 2 Zepbound (tirzepatide) Obesity, Type 2 Diabetes $349–$1,000 Covered by some plans; Eli Lilly offers savings programs 3 Humira (adalimumab) Rheumatoid Arthritis, Crohn’s Disease, Psoriasis ~$9,065 (list price); copays often <$100 with assistance Widely covered; manufacturer copay cards available 4 Enbrel (etanercept) Rheumatoid Arthritis, Psoriasis ~$8,717 (list price); copays often <$100 with assistance Covered by most plans; savings programs available 5 Dupixent (dupilumab) Eczema, Asthma, Nasal Polyps ~$3,000 (list price); many pay <$100/month Covered by many plans; manufacturer assistance available 6 Avonex (interferon beta-1a) Multiple Sclerosis ~$7,000 (list price); copays vary Covered by most plans; assistance programs available 7 Copaxone (glatiramer acetate) Multiple Sclerosis ~$6,000 (list price); copays vary Covered by most plans; assistance programs available 8 Gleevec (imatinib) Chronic Myeloid Leukemia ~$8,000 (list price); copays vary Covered by most plans; assistance programs available 9 Cosentyx (secukinumab) Psoriasis, Psoriatic Arthritis ~$8,907 (list price); copays often <$100 with assistance Covered by most plans; savings programs available 10 Xarelto (rivaroxaban) Blood Clots, Stroke Prevention ~$500 Widely covered; copay cards may reduce cost Key Points:
Insurance Coverage:Most of these medications are covered by insurance plans, but coverage details can vary. It's essential to check with your specific insurance provider.
Manufacturer Assistance:Many pharmaceutical companies offer copay assistance programs or savings cards that can significantly reduce out-of-pocket costs for eligible patients.GoodRx
Cost Variability:The listed prices are approximate and can vary based on dosage, treatment duration, pharmacy, and individual insurance plans.
Alternative Options:For some conditions, there may be generic versions or alternative therapies available that could be more cost-effective.
If you need information on a specific medication, assistance program, or alternative treatment options, feel free to ask!
- Forums
- ASX - By Stock
- BOT
- Ann: March 2025 Quarterly Activities Report and Appendix 4C
BOT
botanix pharmaceuticals ltd
Add to My Watchlist
0.00%
!
29.5¢

Ann: March 2025 Quarterly Activities Report and Appendix 4C, page-191
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
29.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $578.4M |
Open | High | Low | Value | Volume |
29.5¢ | 30.5¢ | 28.3¢ | $3.185M | 10.93M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 160165 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.5¢ | 166 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 142622 | 0.290 |
19 | 671571 | 0.285 |
38 | 816528 | 0.280 |
17 | 672142 | 0.275 |
12 | 280241 | 0.270 |
Price($) | Vol. | No. |
---|---|---|
0.295 | 166 | 1 |
0.300 | 458178 | 9 |
0.305 | 736311 | 11 |
0.310 | 507305 | 10 |
0.315 | 239523 | 2 |
Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online